Journey Medical Corp
NASDAQ:DERM
Journey Medical Corp
NASDAQ:DERM
Price:
5.61 USD
19.36%
Market Closed
Updated:
Jun 11, 2024
Balance Sheet
Balance Sheet Decomposition
Journey Medical Corp
Journey Medical Corp
| Current Assets | 47m |
| Cash & Short-Term Investments | 24.1m |
| Receivables | 9.8m |
| Other Current Assets | 13.2m |
| Non-Current Assets | 19.6m |
| PP&E | 79k |
| Intangibles | 19.5m |
| Other Non-Current Assets | 6k |
| Current Liabilities | 38.9m |
| Accounts Payable | 15.5m |
| Accrued Liabilities | 20.4m |
| Other Current Liabilities | 3m |
| Non-Current Liabilities | 14.7m |
| Long-Term Debt | 14.7m |
Balance Sheet
Journey Medical Corp
Journey Medical Corp
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
5
|
8
|
49
|
32
|
27
|
|
| Cash |
5
|
8
|
49
|
32
|
27
|
|
| Total Receivables |
19
|
24
|
23
|
28
|
15
|
|
| Accounts Receivables |
19
|
24
|
23
|
28
|
15
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
10
|
14
|
10
|
|
| Other Current Assets |
1
|
2
|
2
|
3
|
4
|
|
| Total Current Assets |
25
|
35
|
85
|
78
|
56
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
7
|
15
|
13
|
27
|
20
|
|
| Other Long-Term Assets |
1
|
2
|
0
|
0
|
0
|
|
| Total Assets |
34
N/A
|
52
+53%
|
97
+87%
|
105
+8%
|
77
-27%
|
|
| Liabilities | ||||||
| Accounts Payable |
2
|
2
|
23
|
37
|
18
|
|
| Accrued Liabilities |
19
|
22
|
23
|
20
|
20
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
5
|
5
|
5
|
3
|
|
| Other Current Liabilities |
0
|
0
|
0
|
5
|
0
|
|
| Total Current Liabilities |
21
|
28
|
52
|
67
|
42
|
|
| Long-Term Debt |
10
|
13
|
4
|
21
|
15
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
31
N/A
|
42
+34%
|
55
+33%
|
88
+60%
|
56
-36%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
5
|
39
|
69
|
72
|
|
| Additional Paid In Capital |
3
|
5
|
81
|
86
|
93
|
|
| Total Equity |
3
N/A
|
10
+268%
|
42
+308%
|
17
-60%
|
20
+20%
|
|
| Total Liabilities & Equity |
34
N/A
|
52
+53%
|
97
+87%
|
105
+8%
|
77
-27%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
16
|
16
|
17
|
18
|
19
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
